Isolation and characterization of the human Cdc2L1 gene promoter

Amber Kahle1, Yongmei Feng, Mark A Nelson

  • 1Department of Pathology, Room 5208, Arizona Cancer Center, University of Arizona, 1501 N. Campbell Avenue, Tucson, AZ 85724, United States.

Gene
|January 20, 2005
PubMed

Insights

This study characterizes the Cdc2L1 gene promoter, revealing key regulatory elements like Ets-1 and Skn-1 binding sites essential for cyclin-dependent kinase 11 (CDK11) gene expression.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Biochemistry

Background:

  • Cyclin-dependent kinase 11 (CDK11), also known as PITSLRE, is involved in crucial cellular processes.
  • CDK11 is encoded by two genes, Cdc2L1 and Cdc2L2, with prior research focusing on Cdc2L2 promoter regulation.

Purpose of the Study:

  • To identify and characterize the transcriptional regulatory elements of the human Cdc2L1 gene promoter.
  • To elucidate the specific transcription factors that bind to and regulate Cdc2L1 gene expression.

Main Methods:

  • Cloning and deletion analysis of the Cdc2L1 promoter region.
  • Sequencing to identify GC-rich regions and transcription factor binding sites.
  • Site-directed mutagenesis, transfection studies, and chromatin immunoprecipitation (ChIP) assays.

Main Results:

  • A core promoter region (-152 to +11) essential for basal Cdc2L1 transcription was identified.
  • This region is GC-rich and lacks TATA/CAAT boxes but contains binding sites for Ets-1, Skn-1, and E2F-1.
  • Ets-1 and Skn-1 binding sites were found to be critical for transcriptional activity, with in vivo association confirmed by ChIP.

Conclusions:

  • The study elucidates the transcriptional regulation of the Cdc2L1 gene promoter.
  • Identified Ets-1 and Skn-1 as key transcription factors driving CDK11 expression via the Cdc2L1 promoter.
  • Provides a deeper understanding of the fundamental mechanisms governing CDK11 gene expression.